The malate–aspartate shuttle in gastric atrophy and precancerous progression: an emerging redox–bioenergetic axis
Frontiers in Molecular Biosciences · 05.11.2026 · 13
DOI: 10.3389/fmolb.2026.2000435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Molecular Biosciences, online erschienen am 05.11.2026. Verfasst von Liu Yang und 8 weiteren Autor:innen. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gastric atrophy is a precursor of intestinal-type gastric cancer and is associated with mitochondrial and metabolic abnormalities. The malate–aspartate shuttle (MAS) couples cytosolic NADH oxidation to mitochondrial metabolism and intersects with glycolysis, the tricarboxylic acid cycle, aspartate metabolism, and biosynthesis. This review distinguishes direct gastric observations from mechanistic evidence obtained in other systems. Gastric studies report heterogeneous mitochondrial, metabolite, and component-level findings in different histological and etiological settings. Prospective tissue and plasma omics studies identify progression-associated signatures, but do not establish a longitudinal MAS trajectory, and integrated shuttle function remains unresolved in gastric atrophy and intestinal metaplasia. We consider three context-dependent interpretations: secondary remodeling, a maladaptive contribution to injury, and protective adaptation. These roles may coexist or change over time rather than form mutually exclusive categories. Distinguishing them requires defined baseline functional changes, bidirectional perturbations under matched upstream stress, compartment-resolved redox measurements, and complementary enzyme/carrier interventions linked to gastric phenotypes. Reconstituted shuttle activity must also be distinguished from endogenous flux in intact cells. The MAS provides a hypothesis-generating framework for gastric redox–bioenergetic research; its disease-stage behavior, causal significance, and therapeutic direction require direct validation.
Zitieren
APA
Yang, L., Pang, Z., Li, B., Yan, C., Wang, H., Liu, Z., Wang, S., Li, D., & Yang, Q. (2026). The malate–aspartate shuttle in gastric atrophy and precancerous progression: an emerging redox–bioenergetic axis. Frontiers in Molecular Biosciences, 13. https://doi.org/10.3389/fmolb.2026.2000435
Vancouver
Yang L, Pang Z, Li B, Yan C, Wang H, Liu Z, et al. The malate–aspartate shuttle in gastric atrophy and precancerous progression: an emerging redox–bioenergetic axis. Frontiers in Molecular Biosciences. 2026;13. doi:10.3389/fmolb.2026.2000435
BibTeX
@article{Yang2026,
author = {Yang, Liu and Pang, Zixin and Li, Bolin and Yan, Chenxi and Wang, Hongxia and Liu, Zhiyao and Wang, Shaopo and Li, Diangui and Yang, Qian},
title = {The malate–aspartate shuttle in gastric atrophy and precancerous progression: an emerging redox–bioenergetic axis},
journal = {Frontiers in Molecular Biosciences},
year = {2026},
volume = {13},
doi = {10.3389/fmolb.2026.2000435}
}
EUVIMED